The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

1. Association between COVID-19 and myasthenia gravis (MG): A genetic correlation and Mendelian randomization study.Brain and behavior · 2023
   Article
2. Letter response to "The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis".Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
   Article

Corrections and comments

• Commented on by
  Letter response to "The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis".2022
• Commented on by
  Reply to Letter response to "The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis".2022
• Comment on
  Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review.2022

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as